NIH 2016 UH2 HL |
Conproject-001 Solway, Julian; McCormick, David L. / University of Chicago |
$566,296 |
NIH 2016 UH2 HL |
Conproject-002 Solway, Julian; McCormick, David L. / University of Chicago |
$8,650 |
NIH 2016 UH2 HL |
Conproject-003 Solway, Julian; McCormick, David L. / University of Chicago |
$96,900 |
NIH 2016 UH2 HL |
Conproject-004 Solway, Julian; McCormick, David L. / University of Chicago |
$316,926 |
NIH 2016 UH2 HL |
Conproject-005 Solway, Julian; McCormick, David L. / University of Chicago |
$149,623 |
NIH 2015 UH2 HL |
Preclinical development of myosolvins, a new class of medicine for asthma Solway, Julian; McCormick, David L. / University of Chicago |
$1,714,997 |
NIH 2014 UH2 HL |
Preclinical development of myosolvins, a new class of medicine for asthma Solway, Julian; McCormick, David L. / University of Chicago |
$1,761,373 |